In vivo effects of tumor necrosis factor-α on capillary permeability and vascular tone in a skeletal muscle

Acta Anaesthesiologica Scandinavica

Volumn 40, Issue 2, 1996, Pages 256-261

  Jahr, J ^a,b   Grande P O ^a  

^a LUND UNIVERSITY   (Sweden)

^b Dept of Physiology ^*  (Sweden)

Author keywords

Capillary permeability; Hydrostatic capillary pressure; TNF; Tumor necrosis factor; Vascular resistance

Indexed keywords

CHLORALOSE; TUMOR NECROSIS FACTOR ALPHA; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CAT; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; VASCULAR RESISTANCE; VASODILATATION;

EID: 0030068023     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1996.tb04429.x     Document Type: Article

References (33)

1. Sjölin J. Manipulation of the immunoinflammatory reaction in clinical sepsis. Acta Anaesthesiol Scand 1993: 37 (Suppl 98): 20-24.
2. Thijs LG, Groeneveld ABJ, van Lambalgen AA, van den Bos GC. Changes in systemic microvacular permeability in sepsis and septic shock. In: Vincent JL, ed. Update in intensive care and emergency medicine. Berlin, Heidelberg, New York, Tokyo: Springer Verlag, 1986: 275-278.
3. McClain CJ, Henning B, Ott LG, Goldblum S, Young BA. Mechanisms and implications of hypoalbuminemia in head-injuried patients. J Neurosurg 1988: 69: 386-392.
4. Demling RH. Adult respiratory distress syndrome: Current concepts. New Horizons 1993: 1: 388-401.
5. Millar AB, Singer M, Meager A, Foley NM, Johnson N. McI, Rook GAW. Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989: 2: 712-714.
6. Roberts DJ, Davies JM, Evans CC, Bell M, Mostafa SM. Tumour necrosis factor and adult respiratory distress syndrome. Lancet 1989: 2: 1043-1044.
7. Ding AH, Porteu F, Sanchez E, Nathan CF. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J Exp Med 1990: 171: 715-727.
8. Hack CE, Ogilvie AC, Eisele B, Eerenberg AJM, Wagstaff J, Thijs LG. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med 1993: 19 (Suppl 1): 19-28.
9. Kirkpatrick CJ, Klosterhalfen B, Hauptmann S. The role of the endothelium in multiple organ failure. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin, Heidelberg, New York, Tokyo: Springer Verlag, 1993: 14-24.
10. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukine-1. J Exp Med 1986: 163: 1363-1375.
11. Stolpen AH, Guinan EC, Fieres W. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 1986: 123: 16-24.
12. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989: 169: 1977-1991.
13. Henning B, Goldblum S, McClain C. Interleukine-1 (IL-1) and tumor necrosis factor/cachectin (TNF) increase endothelial permeability in vitro. J Leuk Biol 1987: 42: 551-552.
14. Beynon HLC, Haskard DO, Davies KO, Haroutunian R, Walport MJ. Combination of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol 1993: 91: 314-319.
15. Royall JA, Berkow RL, Beckman JS, Cunningham NK, Matalon S, Freeman BA. Tumor necrosis factor and interleukin 1α increase vascular endothelial permeability. Am J Physiol 1989: 257: L399-410.
16. Matsuki T, Beach JM, Klindt RL, Duling BR. Modification of vascular reactivity by alteration of intimai permeability: effect of TNF-α. Am J Physiol 1993: 264: H1847-1853.
17. Remick DG, Kunkel RG, Larrick JW, Kunkel SL. Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 1987: 56: 583-590.
18. Henning B, Honchel R, Goldblum SE, McClain CJ. Tumor necrosis factor-mediated hypoalbuminemia in rabbits. J Nutr 1988: 118: 1586-1590.
19. Yi ES, Ulich TR. Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil- dependent microvascular leakage in postcapillary venules. Am J Pathol 1992: 140: 659-663.
20. Bonsignore MR, Valenti A, Spatafora M. Tumor necrosis factor-α does not cause lung edema in rabbits. J Appl Physiol 1992: 73: 173-178.
21. Jahr J, Ekelund U, Grände PO. In vivo effects of prostacyclin on segmental vascular resistances, on myogenic reactivity, and on capillary fluid exchange in cat skeletal muscle. Crit Care Med 1995: 23: 523-531.
22. Mellander S, Björnberg J, Maspers M, Myrhage R. Method for continuous recording of hydrostatic exchange vessel pressure in cat skeletal muscle. Acta Physiol Scand 1987: 129: 325-335.
23. Folkow B, Mellander S . Measurements of capillary filtration coefficient and its use in studies of the control of capillary exchange. In: Crone C and Lassen NA, eds. Capillary permeability. The transfer of molecules and ions between capillary blood and tissue. Copenhagen: Munksgaard, 1970: 614-623.
24. Cobbold A, Folkow B, Kjellmer I, Mellander S. Nervous and local chemical control of pre-capillary sphincters in skeletal muscle as measured by changes in filtration coefficient. Acta Physiol Scand 1963: 57: 180-192.
25. Morel NML, Petruzzo PP, Hechtmann HB, Shepro D. Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured endothelial cell contraction. Inflammation 1990: 14: 571-583.
26. Suffredini AF, Fromm RE, Parker M, Brenner M, Kovacs JA, Wesley RA, Parillo JE . The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989: 321: 280-287.
27. Vicaut E, Hou X, Payen D, Buosseau A, Tedgui A. Acute effects of rumor necrosis factor on the microcirculation in rat cremaster muscle. J Clin Invest 1991: 87: 1537-1540.
28. Tracey K, Cerami A. Tumor necrosis factor: An updated review of its biology. Crit Care Med 1993: 21: (Suppl.): 415-422.
29. Spooner CE, Markowitz NP, Saravolatz LD. The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 1992: 62: (Suppl.): 11-17.
30. Cerami A. Inflammatory cytokines. Clin Immunol Immunopathol 1992: 62: (Suppl.): 3-10.
31. Lundvall J. Tissue hyperosmolality as a mediator of vaso-dilation and transcapillay fluid flux in exercising skeletal muscle. Acta Physiol Scand 1972: 379: (Suppl.): 1-142.
32. Tracey KJ, Lowrry SF, Fahey TJ, Albert JD, Fong Y, Hesse D, et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987: 164: 415-422.
33. Martin C, Saux P, Mege JL, Perrin G, Papazian L, Gouin F. Prognostic values of serum cytokines in septic shock. Intensive Care Med 1994: 20: 272-277.